How some breast cancer treatments can impact fertility
Different breast cancer treatments can affect fertility in different ways. Here, we’ll talk about the ways that chemotherapy and hormonal therapy, two common treatments, can impact fertility.
Chemotherapy
Chemotherapy can affect fertility by damaging the DNA in immature egg cells in the ovaries. This means having fewer eggs than you did before chemotherapy.
Chemotherapy can also cause the ovaries to stop releasing eggs and making estrogen. This can trigger premature menopause, sometimes called medical menopause, in some women. After menopause, you can no longer get pregnant. But the younger you are, the lower the risk of chemotherapy-related menopause, especially if you’re under age 40.
Chemotherapy’s long-term effects on fertility depend on your dose and your age. Certain types of chemotherapy pose higher risks than others:
Some doctors advise not getting pregnant for at least 6 months after chemotherapy is finished. Others suggest waiting at least 2 years before trying to have a baby. The longer time frame increases the chances you have fully recovered from chemotherapy and also helps you and your care team make sure the cancer has not returned.
In a study published in 2019, researchers tested the effect of an ovarian suppression medicine called goserelin on fertility of women being treated for hormone receptor-negative breast cancer. The study showed that when women took the medicine with chemotherapy, their ovaries were protected from the effects of chemotherapy and they were more likely to have a baby after treatment. Research on this treatment combination, and its effects on fertility, is ongoing.
If you think you want to have children in the future, let your doctor know as early as possible before treatment starts. Ask to be referred to a fertility specialist to talk about options, such as freezing eggs or embryos for later use.
Hormonal therapy
Hormonal therapy can have an impact on your menstrual cycle and your fertility:
- It can cause irregular periods, or cause periods to stop, although you could still be fertile.
- It’s usually taken for 5 to 10 years, which can interfere with the timing of having a family.
It’s also important to know that hormonal therapy can harm an unborn baby, and cannot be taken while pregnant. That’s why your doctor may suggest using a long-acting non-hormonal reversible contraceptive (birth control) such as a copper IUD or barrier birth control such as a diaphragm or condoms while taking hormonal therapy.
Three types of hormonal therapy are approved for premenopausal women:
- Tamoxifen. Tamoxifen’s greatest effect on your fertility may come from the time delay caused by the recommended 5 to 10 years of treatment. Adding 5 to 10 years may push you into menopause, especially if you have also had chemotherapy. Even if you are not in menopause when you finish treatment, the older you are, the harder it is to become pregnant. Research suggests that taking tamoxifen for 2 or 3 years, pausing it to try to get pregnant, and then finishing the treatment after having a baby may be an option for some women. It’s important to know that it is possible to get pregnant while taking tamoxifen, but tamoxifen can harm a fetus. Doctors advise waiting at least 2 months after pausing or ending tamoxifen treatment before trying to become pregnant.
- Centrally acting hormone blockers, such as goserelin (Zoladex) and leuprolide (Lupron), are medicines that temporarily suppress ovarian function. These treatments lower estrogen levels so that estrogen receptor-positive breast cancer cells can’t continue to grow. When taken during chemotherapy, GnRH agonists can have a protective effect on fertility by telling the brain not to signal the ovaries to develop an egg that could potentially be harmed by chemotherapy.
- Aromatase inhibitors. While aromatase inhibitors, such as anastrozole (Arimidex), exemestane (Aromasin), and letrozole (Femara) used to be given only to postmenopausal women, they can now be given to premenopausal women in combination with medicines such as goserelin or leuprolide. Aromatase inhibitors in combination with ovarian suppression medicines have been shown to be more effective against estrogen receptor-positive breast cancer than tamoxifen. Aromatase inhibitors are usually given for 5 years.
If hormonal therapy has been recommended for you and you want to have children, talk with your care team about your individual situation.
To learn more about timing hormonal therapy and starting a family, visit Getting pregnant after early breast cancer. You can also watch one woman’s video story about pausing tamoxifen to have a baby.